Jeong Cho

manager at ALTEOGEN Inc. - , ,

Jeong Cho's Colleagues at ALTEOGEN Inc.
Chang-Hun Lee

Project Coordination Manager

Contact Chang-Hun Lee

Vivek Shenoy

Senior Vice President, Chief Business Officer

Contact Vivek Shenoy

Sunbae Lee

Director of Regulatory Affairs

Contact Sunbae Lee

Allan Kang

경영지원본부장

Contact Allan Kang

View All Jeong Cho's Colleagues
Jeong Cho's Contact Details
HQ
N/A
Location
South Korea
Company
ALTEOGEN Inc.
Jeong Cho's Company Details
ALTEOGEN Inc. logo, ALTEOGEN Inc. contact details

ALTEOGEN Inc.

, , • 100 - 249 Employees
Other

ALTEOGEN Inc., Daejeon(fifth-largest metropolis)-based in South Korea, is a leading biopharmaceutical company with a leading edge pipeline of novel biologics such as next generation biobetters including long-acting therapeutic proteins, Antibody-Drug Conjugate (ADC) therapeutic antibodies and monoclonal antibody biosimilars. The company was founded in 2008 and listed in KOSDAQ stock market (KRX:196170). Our innovative NexP™ fusion technology is applied to various proteins and peptides to allow longer activities in human beings. Long-acting human Growth Hormone, long-acting exenatide (for diabetes) and long-acting Factor VIIa (for hemophilia) are developed with the NexP™ fusion technology. Our proprietary ADC technology, NexMab™ ADC technology is well suited for the targeted therapy for the cancer drugs with lower side effect and better efficacy. With this NexMab™ ADC technology, we are developing ADC therapeutics for breast/gastric cancer and ovarian cancer. Alteogen's mostly distinguished Hybrozyme™ technology to a human hyaluronidase, which has been widely used to improve the absorption of drug biologics delivered via subcutaneous injection. The novel human hyaluronidase based on Hybrozyme™ technology showed improved enzymatic activity and thermal stability.Based on long and rich experiences, Alteogen has quickly developed its own cell lines with high expression, efficient process (upstream and downstream), and optimized analysis methods for monoclonal antibody biosimilars including Herceptin preparing for the phase 3 trials upon completion of global phase 2 testing, SC formulation of Herceptin biosimilar as well as working on Eylea biosimilar.

N/A
Details about ALTEOGEN Inc.
Frequently Asked Questions about Jeong Cho
Jeong Cho currently works for ALTEOGEN Inc..
Jeong Cho's role at ALTEOGEN Inc. is manager.
Jeong Cho's email address is ***@alteogen.com. To view Jeong Cho's full email address, please signup to ConnectPlex.
Jeong Cho works in the Research industry.
Jeong Cho's colleagues at ALTEOGEN Inc. are Chang-Hun Lee, Jihye Han, Vivek Shenoy, Sunbae Lee, Tae-Ho Kang, Soon Park, Allan Kang and others.
Jeong Cho's phone number is N/A
See more information about Jeong Cho